Article
In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
BMC neuroscience - 7 Apr 2009
Westman Eric, Spenger Christian, Oberg Johanna, Reyer Henry, Pahnke Jens, Wahlund Lars-Olof
Abstract excerpt
BACKGROUND: Donepezil improves cognitive functions in AD patients. Effects on the brain metabolites N-acetyl-L-aspartate, choline and myo-inositol levels have been reported in clinical studies using this drug. The APP/PS1 mouse coexpresses the mutated forms of human beta-amyloid precursor protein (APP) and mutated human presenilin 1 (PS1). Consequently, the APP/PS1 mouse model reflects important features of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
